Streptococcus sanguinis is often found in subgingival biofilm
including periodontopathogens, and is correlated with
a delay in colonization by periodontopathogens. However,
the effect of S. sanguinis on inflammation induced by periodontopathogens
is poorly understood. Thus, this study investigated
the effect of S. sanguinis peptidoglycan (PGN) on
induction of TNF-α, IL-6, and IL-8 expression by lipopolysaccharide
(LPS) of periodontal pathogens. LPS was extracted
from Aggregatibacter actinomycetemcomitans, Porphyromonas
gingivalis, and Tannerella forsythia, and PGN was isolated
from S. sanguinis. THP-1 cells, a monocytic cell-line, were cotreated
with LPS of the periodontal pathogens and S. sanguinis
PGN, and then the expression of inflammatory cytokines
was analyzed by real-time RT-PCR. To analyze the underlying
mechanism, the binding assay of the LPS to CD14
or LPS-binding protein (LBP) was performed in the presence
or absence of the PGN after coating recombinant human
CD14 and LBP on EIA plate. The PGN inhibited the binding
of LPS to CD14 and LBP in a dose-dependent manner.
Also, THP-1 cells were co-treated with the LPS in the presence
of N-acetylmuramic acid and N-acetylglucosamine,
as components of PGN, and the competition binding assay
to CD14 and LBP was performed. N-acetylmuramic acid inhibited
the induction of inflammatory cytokine expression
by LPS and the binding of LPS to CD14 or LBP whereas Nacetylglucosamine
did not show such effect. Collectively, the
results
suggest that S. sanguinis PGN inhibited the cytokine
expression induced by the LPS of periodontopathogens due
to the inhibition of LPS binding to LBP and CD14. N-acetylmuramic
acid of PGN may play a role in inhibition of
the LPS binding of periodontopathogens to CD14 and LBP.